NRx Pharmaceuticals Announces Positive Safety Report for ZYESAMI™ (aviptadil) in NIH ...

Retrieved on: 2021-08-18 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

NRx Pharmaceuticals Announces Positive Safety Report for ZYESAMI™ (aviptadil) in NIH .... View article details on HISWAI: https://www.mdjonline.com/neighbor_newspapers/news/national/nrx-pharmaceuticals-announces-positive-safety-report-for-zyesami-aviptadil-in-nih-sponsored-activ-3-critical/article_498a0044-5331-5038-86d9-c0bfbc19c157.html

Excerpt

ACTIV-3 is a randomized, blinded, placebo-controlled clinical trial testing ZYESAMI™ and the antiviral remdesivir (Veklury) in hospitalized patients ...

Article found on: www.mdjonline.com

View Original Article